AGREE OF THE CANNABIS Smoking Craze
Cannabis smoking is also on the rise, despite the misconception that it is innocent, despite the quick and unstable risks that drug-infused vapes pose.
This presumption is risky. Cannabis is addictive, but it can also lead to memory loss, illness, and breathing problems.
Also, many cannabis vapes contain added health risks. One of the most well-known is vitamin E ester, which has been linked to the primary cause of EVALI (e-cigarette or vaping-associated lung damage ), a fatal condition that claimed 68 lives and infected over 2,800 people in the US between 2019 and 2020.
Despite these dangers, the cannabis-related craze is becoming difficult to stop. The tobacco industry has made significant investments in the smoking sector, and it is now gaining market share in hemp.
For instance, it was reported that Philip Morris International ( PMI ) was acquiring Israeli cannabis asthma company Syqe Medical for US$ 650 million in 2023. Additionally, PMI and French company Avicanna formed a relationship in January of this year.
In addition, Marlboro-maker Altria Group controls the majority of the shares of Canadian cannabis producer OrganiGram, while British American Tobacco ( BAT ) controls a majority of the shares of Canadian cannabis producer OrganiGram.
Many of these businesses advertise themselves as experts in cannabis studies or therapy. However, the tobacco industry’s track record for goods protection raises serious questions about its ability to create healthy vapes.
Cigars are the only legal consumer goods that, when used exactly as intended by the manufacturer, kill about half of its people, which is a staggering number considering there are an estimated 1.3 billion cigarettes worldwide.